EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Is uniform D2 still biologically optimal in gastric cancer? Lymphadenectomy in the immunotherapy era

Wojciech P Polkowski, Lucjan S Wyrwicz

European Journal of Surgical Oncology · 2026-11 · 52 (11) · 112097

DOI: 10.1016/j.ejso.2026.112097 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Surgical Oncology, 2026-11. Verfasst von Wojciech P Polkowski und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Medical University of Lublin, Lublin, Poland. Electronic address: wojciech.polkowski@umlub.edu.pl. Hauptthemen laut MEDLINE: Stomach Neoplasms, Lymph Node Excision, Immunotherapy, Lymph Nodes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

D2 lymphadenectomy remains the accepted oncological standard for resectable gastric cancer (GC). However, the increasing integration of perioperative immunotherapy and emerging insights into tumour-draining lymph node (TDLN) immunobiology raise questions regarding whether a uniformly anatomical approach to nodal dissection will remain biologically optimal across all treatment contexts. While lymphadenectomy provides essential locoregional control and pathological staging, TDLN may also function as immunologically active structures involved in antigen presentation, T-cell priming, and systemic antitumour immunity. Current evidence does not support de-escalation of D2 lymphadenectomy, given persistent uncertainty regarding residual nodal disease and the limitations of available response-assessment tools. Nevertheless, future lymphadenectomy strategies may evolve toward greater biological contextualisation integrating tumour biology, immune function, treatment response, and molecular heterogeneity. Whether surgical radicality should ultimately undergo comparable biological refinement remains an increasingly relevant question.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsLymph Node ExcisionImmunotherapyLymph NodesHumansNeoplasm StagingGastrectomyLymphatic Metastasis

Stichwörter der Autor:innen

D2 lymphadenectomyGastric cancerGastric surgeryImmunotherapyPerioperative treatmentTumour-draining lymph nodes

Autor:innen und Institutionen

  • Department of Surgical Oncology, Medical University of Lublin, Lublin, Poland. Electronic address: wojciech.polkowski@umlub.edu.pl.
  • Department of Oncology and Radiotherapy, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.

Zitieren

APA

Polkowski, W. P., & Wyrwicz, L. S. (2026). Is uniform D2 still biologically optimal in gastric cancer? Lymphadenectomy in the immunotherapy era. European Journal of Surgical Oncology, 52(11), 112097. https://doi.org/10.1016/j.ejso.2026.112097

Vancouver

Polkowski WP, Wyrwicz LS. Is uniform D2 still biologically optimal in gastric cancer? Lymphadenectomy in the immunotherapy era. European Journal of Surgical Oncology. 2026;52(11):112097. doi:10.1016/j.ejso.2026.112097

BibTeX
@article{Polkowski2026,
  author = {Polkowski, Wojciech P and Wyrwicz, Lucjan S},
  title = {Is uniform D2 still biologically optimal in gastric cancer? Lymphadenectomy in the immunotherapy era},
  journal = {European Journal of Surgical Oncology},
  year = {2026},
  volume = {52},
  number = {11},
  pages = {112097},
  doi = {10.1016/j.ejso.2026.112097}
}
Kostenlos starten →